Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO

Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO

Source: 
Xconomy
snippet: 

Reforms to a US national security regulation are putting off foreign investors and driving down VC investment in the biotech space by as much as 20 percent, says BIO’s David Thomas.